Vanda Pharmaceuticals Inc (VNDA)
4.775
+0.02
(+0.53%)
USD |
NASDAQ |
May 01, 16:00
4.775
0.00 (0.00%)
After-Hours: 19:38
Vanda Pharmaceuticals Cash from Operations (Quarterly): -3.732M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -3.732M |
September 30, 2023 | -2.05M |
June 30, 2023 | -13.22M |
March 31, 2023 | 31.80M |
December 31, 2022 | 9.416M |
September 30, 2022 | 12.84M |
June 30, 2022 | 5.685M |
March 31, 2022 | 4.046M |
December 31, 2021 | 26.61M |
September 30, 2021 | 9.397M |
June 30, 2021 | 19.02M |
March 31, 2021 | 9.193M |
December 31, 2020 | 19.30M |
September 30, 2020 | 9.374M |
June 30, 2020 | 24.01M |
March 31, 2020 | -0.907M |
December 31, 2019 | 9.791M |
September 30, 2019 | 5.998M |
June 30, 2019 | 20.52M |
March 31, 2019 | 9.643M |
December 31, 2018 | 15.26M |
September 30, 2018 | 8.694M |
June 30, 2018 | 4.391M |
March 31, 2018 | 1.638M |
December 31, 2017 | 3.466M |
Date | Value |
---|---|
September 30, 2017 | 2.168M |
June 30, 2017 | -2.26M |
March 31, 2017 | -5.357M |
December 31, 2016 | -1.183M |
September 30, 2016 | 1.241M |
June 30, 2016 | -3.262M |
March 31, 2016 | -4.899M |
December 31, 2015 | -0.356M |
September 30, 2015 | -4.851M |
June 30, 2015 | 12.10M |
March 31, 2015 | 5.555M |
December 31, 2014 | -13.39M |
September 30, 2014 | -7.599M |
June 30, 2014 | -36.66M |
March 31, 2014 | -23.90M |
December 31, 2013 | -12.15M |
September 30, 2013 | -10.27M |
June 30, 2013 | -8.043M |
March 31, 2013 | -9.125M |
December 31, 2012 | -13.85M |
September 30, 2012 | -10.16M |
June 30, 2012 | -12.21M |
March 31, 2012 | -8.69M |
December 31, 2011 | -12.36M |
September 30, 2011 | -7.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.22M
Minimum
Jun 2023
31.80M
Maximum
Mar 2023
10.37M
Average
9.397M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
ADMA Biologics Inc | 17.60M |
INVO Bioscience Inc | -0.7149M |
Johnson & Johnson | 7.863B |
Nektar Therapeutics | -47.05M |
Invivyd Inc | -59.24M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -43.78M |
Free Cash Flow | 12.42M |
Free Cash Flow Per Share (Quarterly) | -0.0691 |
Free Cash Flow to Equity (Quarterly) | -3.985M |
Free Cash Flow to Firm (Quarterly) | -3.985M |
Free Cash Flow Yield | 4.52% |